Compare Stocks: CPHI, UTZ, SBTX, and CRDL

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CPHI China Pharma	$0.87 -9.3%	$0.88	$0.38 ▼ $19.19	$37.45M	1.04	2.05 million shs	2.18 million shs
CRDL Cardiol Therapeutics	$1.23 -5.4%	$1.77	$0.88 ▼ $2.34	$146.28M	0.88	1.63 million shs	1.26 million shs
SBTX Silverback Therapeutics	$4.23 -7.2%	$5.16	$2.80 ▼ $8.97	$152.53M	0.6	337,931 shs	1.26 million shs
UTZ Utz Brands	$14.31 -0.1%	$14.21	$6.78 ▼ $14.33	$2.06B	0.72	1.68 million shs	5.54 million shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CPHI China Pharma	-9.32%	+32.50%	+11.75%	+52.72%	-55.92%
CRDL Cardiol Therapeutics	-5.38%	-12.77%	-46.29%	+21.78%	+13.89%
SBTX Silverback Therapeutics	+4.59%	+10.68%	-15.40%	-42.57%	-55.86%
UTZ Utz Brands	-0.07%	+0.28%	+0.63%	+82.14%	+19.51%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CPHI China Pharma	$0.87 -9.3%	$0.88	$0.38 ▼ $19.19	$37.45M	1.04	2.05 million shs	2.18 million shs
CRDL Cardiol Therapeutics	$1.23 -5.4%	$1.77	$0.88 ▼ $2.34	$146.28M	0.88	1.63 million shs	1.26 million shs
SBTX Silverback Therapeutics	$4.23 -7.2%	$5.16	$2.80 ▼ $8.97	$152.53M	0.6	337,931 shs	1.26 million shs
UTZ Utz Brands	$14.31 -0.1%	$14.21	$6.78 ▼ $14.33	$2.06B	0.72	1.68 million shs	5.54 million shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CPHI China Pharma	-9.32%	+32.50%	+11.75%	+52.72%	-55.92%
CRDL Cardiol Therapeutics	-5.38%	-12.77%	-46.29%	+21.78%	+13.89%
SBTX Silverback Therapeutics	+4.59%	+10.68%	-15.40%	-42.57%	-55.86%
UTZ Utz Brands	-0.07%	+0.28%	+0.63%	+82.14%	+19.51%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CPHI China Pharma	0.00	N/A	N/A	N/A
CRDL Cardiol Therapeutics	2.50	Moderate Buy	$10.00	713.01% Upside
SBTX Silverback Therapeutics	0.00	N/A	N/A	N/A
UTZ Utz Brands	2.00	Hold	$13.39	-6.42% Downside

Current Analyst Ratings Breakdown

Latest CPHI, UTZ, SBTX, and CRDL Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/23/2026	CRDL Cardiol Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$9.00
9/21/2026	CRDL Cardiol Therapeutics	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
9/21/2026	UTZ Utz Brands	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
8/26/2026	CRDL Cardiol Therapeutics	B. Riley Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$11.00
8/17/2026	CRDL Cardiol Therapeutics	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$8.00 ➝ $10.00
7/27/2026	UTZ Utz Brands	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold
7/23/2026	UTZ Utz Brands	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight ➝ Neutral	$10.00 ➝ $14.25
7/22/2026	UTZ Utz Brands	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$14.25
7/22/2026	UTZ Utz Brands	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral	$15.00 ➝ $14.25
7/22/2026	UTZ Utz Brands	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/22/2026	UTZ Utz Brands	DA Davidson Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$15.00 ➝ $14.25

(Data available from 10/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CPHI China Pharma	$3.91M	9.57	N/A	N/A	$0.70 per share	1.24
CRDL Cardiol Therapeutics	N/A	N/A	N/A	N/A	$0.11 per share	N/A
SBTX Silverback Therapeutics	N/A	N/A	N/A	N/A	$7.41 per share	N/A
UTZ Utz Brands	$1.44B	1.43	$1.41 per share	10.17	$9.41 per share	1.52

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CPHI China Pharma	-$3.08M	-$0.43	N/A	N/A	N/A	-85.56%	-63.93%	-31.42%	N/A
CRDL Cardiol Therapeutics	-$24.20M	-$0.25	N/A	N/A	N/A	N/A	-180.44%	-140.28%	11/12/2026 (Estimated)
SBTX Silverback Therapeutics	-$89.48M	-$2.42	N/A	N/A	N/A	N/A	-29.62%	-28.20%	N/A
UTZ Utz Brands	$800K	-$0.33	N/A	16.63	N/A	-2.00%	8.97%	4.32%	10/29/2026 (Estimated)

Latest CPHI, UTZ, SBTX, and CRDL Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
10/29/2026	Q3 2026	UTZ Utz Brands	$0.2256	N/A	N/A	N/A	$385.05 million	N/A
8/13/2026	Q2 2026	CRDL Cardiol Therapeutics	-$0.09	-$0.04	+$0.05	-$0.04	N/A	N/A
8/5/2026	Q2 2026	UTZ Utz Brands	$0.1847	$0.19	+$0.0053	-$0.11	$374.18 million	$371.80 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CPHI China Pharma	N/A	N/A	N/A	N/A	N/A
CRDL Cardiol Therapeutics	N/A	N/A	N/A	N/A	N/A
SBTX Silverback Therapeutics	N/A	N/A	N/A	N/A	N/A
UTZ Utz Brands	$0.25	1.75%	+18.77%	N/A	3 Years

Latest CPHI, UTZ, SBTX, and CRDL Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
9/10/2026	UTZ Utz Brands	quarterly	$0.0630	1.77%	9/21/2026	9/21/2026	10/1/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CPHI China Pharma	0.22	0.79	0.26
CRDL Cardiol Therapeutics	N/A	5.55	5.55
SBTX Silverback Therapeutics	N/A	67.87	67.87
UTZ Utz Brands	0.62	1.06	0.69

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CPHI China Pharma	N/A
CRDL Cardiol Therapeutics	12.49%
SBTX Silverback Therapeutics	74.89%
UTZ Utz Brands	95.97%

Insider Ownership

Company	Insider Ownership
CPHI China Pharma	6.40%
CRDL Cardiol Therapeutics	5.25%
SBTX Silverback Therapeutics	34.40%
UTZ Utz Brands	12.73%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CPHI China Pharma	221	43.02 million	15.92 million	Not Optionable
CRDL Cardiol Therapeutics	18	118.93 million	112.69 million	Not Optionable
SBTX Silverback Therapeutics	83	36.06 million	23.65 million	Not Optionable
UTZ Utz Brands	3,300	143.96 million	125.64 million	Optionable

CPHI, UTZ, SBTX, and CRDL Headlines

Recent News About These Companies

Utz Brands Brings Its Full Snacking Powerhouse to the 2026 NACS Show; From protein-packed snacks to bold new flavors and fan favorites, Utz Brands showcases a diverse portfolio ...

October 8 at 7:54 PM | marketscreener.comM

Utz Brands stock hits 52-week high at $14.33

October 8 at 7:54 PM | au.investing.com

Utz Brands (NYSE:UTZ) Sets New 1-Year High - Time to Buy?

October 8 at 1:59 PM | marketbeat.com

Utz Brands, Inc. Showcases New Innovations and Fan-Favorite Snacks from Its Portfolio At the 2026 National Association of Convenience Stores Show

October 8 at 4:51 AM | marketscreener.comM

Utz Brands Brings Its Full Snacking Powerhouse to the 2026 NACS Show

October 6, 2026 | finance.yahoo.com

Utz Brands, Inc. (NYSE:UTZ) Stock Has Consensus Target Price of $13.39 According to Analysts

October 6, 2026 | americanbankingnews.com

Utz Brands, Inc. (NYSE:UTZ) Stock Has Average Target Price of $13.39 According to Analysts

October 6, 2026 | marketbeat.com

Utz Launches 3 New Snack Flavors For Fall

October 5, 2026 | theshelbyreport.comT

Intersnack Buyout Delivers 91% Cash Premium for Utz Brands (UTZ) Shareholders

October 5, 2026 | insidermonkey.com

Utz Brands (NYSE:UTZ) and Adecoagro (NYSE:AGRO) Head-To-Head Review

October 4, 2026 | americanbankingnews.com

All You Need to Know About Utz Brands (UTZ) Rating Upgrade to Buy

October 1, 2026 | zacks.com

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Capital Bancorp, Inc. (Nasdaq – CBNK), Lifecore Biomedical, Inc. (Nasdaq – LFCR), MISTRAS Group, Inc. (NYSE – MG), Utz Brands, Inc. (NYSE – UTZ)

September 30, 2026 | globenewswire.com

Your Legal Opinion Is ‘Table Stakes’: GCs Are Being Asked to Bring More to the Business

September 29, 2026 | law.comL

Utz Brands, Inc. bringt Utz Protein Pretzels und Protein Cheese Curls auf den Markt

September 24, 2026 | de.marketscreener.comD

Utz Brands, Inc. Launches Utz Protein Pretzels and Protein Cheese Curls

September 24, 2026 | marketscreener.comM

Utz Snack Squad to Shake up the Afternoon Snack Break in Union Square Park

September 24, 2026 | finance.yahoo.com

Utz Debuts New Chicken Dipping Sauce Potato Chips, Cheddar Bacon Ranch Cheese Balls and Spicy Pickle Bites

September 23, 2026 | marketscreener.comM

Utz expands flavored snack portfolio this fall

September 23, 2026 | snackandbakery.comS

Utz Turns Up the Flavor With Three New Snack Innovations

September 22, 2026 | finance.yahoo.com

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Priority Technology Holdings, Inc. (Nasdaq – PRTH), MISTRAS Group, Inc. (NYSE – MG), The Baldwin Group, Inc. (Nasdaq – BWIN), Utz Brands, Inc. (NYSE – UTZ)

September 22, 2026 | globenewswire.com

Corient Private Wealth LP Acquires 135,239 Shares of Utz Brands, Inc. $UTZ

September 22, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

CPHI, UTZ, SBTX, and CRDL Company Descriptions

China Pharma NYSE:CPHI

$0.87 -0.09 (-9.32%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$0.87 0.00 (-0.29%)

As of 10/9/2026 07:59 PM Eastern

China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. Its products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate injection to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Ozagrel Sodium to treat acute thrombotic cerebral infarction and dyskinesia; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide injection to treat edema diseases; and Candesartan for hypertension. In addition, the company provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Andrographolide for sore throat caused by upper respiratory tract infection; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. Further it offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Additionally, the company provides Vitamin B6 injection; Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors; Noni Enzyme, a food supplement; sanitizers; and masks. It offers its products through distributors, its network of sales offices, and sales representatives. The company is based in Haikou, the People's Republic of China.

Cardiol Therapeutics NASDAQ:CRDL

$1.23 -0.07 (-5.38%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$1.26 +0.03 (+2.20%)

As of 10/9/2026 07:55 PM Eastern

Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. Its lead product CardiolRx, which is in Phase II multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of CardiolRx in acute myocarditis, as well as for the treatment of recurrent pericarditis. The company is also developing CRD-38 injection for subcutaneous administration that is in preclinical development for the treatment of heart failure. It has a license agreement with Meros. The company was incorporated in 2017 and is headquartered in Oakville, Canada.

Silverback Therapeutics NASDAQ:SBTX

$4.23 -0.33 (-7.24%)

As of 10/9/2026

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

Utz Brands NYSE:UTZ

$14.30 -0.02 (-0.10%)

Closing price 10/9/2026 03:59 PM Eastern

Extended Trading

$14.29 -0.01 (-0.09%)

As of 10/9/2026 07:56 PM Eastern

Utz Brands, Inc. engages in manufacture, marketing, and distribution of snack foods. It offers a range of salty snacks, including salty snacks, including potato chips, tortilla chips, pretzels, cheese snacks, pork skins, veggie snacks, pub/party mixes, tortilla chips, salsa and dips, ready-to-eat popcorn, and other snacks under the Utz, Zapp's, ON THE BORDER, Golden Flake, Boulder Canyon, Hawaiian, TORTIYAHS!, etc. The company sells its products to wholesale and other distributors, grocery stores, convenience and drug stores, discount stores, mass merchandisers, membership club stores, hard discounters, and specialty and e-commerce retailers. Utz Brands, Inc. was founded in 1921 and is headquartered in Hanover, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CPHI, UTZ, SBTX, and CRDL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CPHI, UTZ, SBTX, and CRDL Earnings

Compare Dividends

Latest CPHI, UTZ, SBTX, and CRDL Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CPHI, UTZ, SBTX, and CRDL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CPHI, UTZ, SBTX, and CRDL Company Descriptions

China Pharma NYSE:CPHI

Cardiol Therapeutics NASDAQ:CRDL

Silverback Therapeutics NASDAQ:SBTX

Utz Brands NYSE:UTZ

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest CPHI, UTZ, SBTX, and CRDL Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest CPHI, UTZ, SBTX, and CRDL Earnings

Compare Dividends

Latest CPHI, UTZ, SBTX, and CRDL Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

CPHI, UTZ, SBTX, and CRDL Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

CPHI, UTZ, SBTX, and CRDL Company Descriptions

China Pharma NYSE:CPHI

Cardiol Therapeutics NASDAQ:CRDL

Silverback Therapeutics NASDAQ:SBTX

Utz Brands NYSE:UTZ

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools